If you have been reading about circular dichroism and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-07-06. Numbers and descriptions here follow the published literature rather than marketing material.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Approximate composition of the free peptide |
| Molecular weight | Approximately 4813 Da | Calculated for the free base |
| Structural class | Synthetic linear peptide | 39 residues with modified backbone |
| Solubility | Soluble in water and polar solvents | Behavior of the lyophilized solid |
| Typical storage temperature | -20 degrees Celsius or below | Solid form, protected from light |
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
=== Development of synthetic AAS === The development of muscle-building properties of testosterone was pursued in the 1940s, in the Soviet Union and in Eastern Bloc countries such as East Germany, where steroid programs were used to enhance the performance of Olympic and other amateur weight lifters. In response to the success of Russian weightlifters, the U.S. Olympic Team physician John Ziegler worked with synthetic chemists to develop an AAS with reduced androgenic effects. Ziegler's work resulted in the production of metandienone, which Ciba Pharmaceuticals marketed as Dianabol. The new steroid was approved for use in the U.S. by the Food and Drug Administration (FDA) in 1958. It was most commonly administered to burn victims and the elderly. The drug's off-label users were mostly bodybuilders and weight lifters. Although Ziegler prescribed only small doses to athletes, he soon discovered that those having used metandienone developed enlarged prostates and atrophied testes. AAS were placed on the list of banned substances of the International Olympic Committee (IOC) in 1976, and a decade later, the committee introduced "out-of-competition" doping tests because many athletes used AAS in their training period rather than during competition.
== Ecology == Parmotrema perlatum is an important species within specific lichen communities in British woodlands, particularly those in late successional mesotrophic settings in oceanic or humid microclimates. It is associated with the Type K Lobaria pulmonaria-Isothecium myosuroides ecological community. This community type is characterised by its occurrence in mature mesotrophic environments, which are often warmer in winter climates or specific microhabitats. This community includes, in addition to P. perlatum, dominant foliose lichens like Lobaria pulmonaria, Hypotrachyna taylorensis, and Parmotrema crinitum, as well as bryophytes such as Isothecium myosuroides. A 2017 study investigated the physiological responses of Parmotrema perlatum along an aridity gradient in Southern Portugal. The researchers transplanted thalli of P. perlatum to rural and forested sites characterised by varying levels of aridity and measured several physiological parameters, including photosynthetic performance, pigment content, ergosterol content, and sample viability, both before and after a six-month exposure period. The study found that P. perlatum showed lower photosynthetic performance (measured as FV/FM and the performance index on an absorption basis, PIABS) in drier sites compared to more humid sites. In humid environments, the content of photosynthetic pigments increased post-exposure, while in drier sites, this increase was less pronounced. Additionally, ergosterol content was lower in drier sites, indicating a stress response to arid conditions. These results highlight that P.
Additionally, the economic conditions surrounding future interest rate hikes; which could put renewed pressure on valuations, complicate loan refinancing, and impede debt servicing could cause major dislocation in commercial real estate markets. However, the contribution to Europe's economy in 2012 can be estimated at €285 billion according to EPRA and INREV, not to mention social benefits of an efficient real estate sector. It is estimated that commercial property is responsible for securing around 4 million jobs across Europe. As of April 2025, commercial real estate confidence experienced its sharpest drop since the COVID-19 pandemic amid the Trump Administration's latest tariff policies, with positive sentiment falling from 126.5% in the latter half of 2024 to 87.9%, according to the 1Q 2025 Board of Governors Sentiment Index.
According to a study by Colombia's National Centre for Historical Memory, 220,000 people have died in the conflict between 1958 and 2013, most of them civilians (177,307 civilians, 40,787 fighters) and more than five million civilians were forced from their homes between 1985 and 2012, generating the world's second largest population of internally displaced persons (IDPs). The report shows that the humanitarian crisis in Colombia is extremely serious in terms of both lethal and nonlethal violence: it examines the widespread use of sexual violence against women and girls as a weapon of war, as well as the invisibility of this phenomenon. 16.9% of the population in Colombia has been a direct victim of the war. 2.3 million children have been displaced from their homes, and 45,000 children have been killed, according to national figures cited by Unicef. In total, one in three of the 7.6 million registered victims of the conflict are children, and since 1985, 8,000 minors have disappeared. As of 2016, some 1,000 children have been forcibly recruited by some of the myriad armed groups in the country, 75 have been killed, and 65 schools have been damaged by fighting since peace talks with FARC began. According to the report "Basta ya", written in 2013 by Colombia's National Centre for Historical Memory, 80% of victims affected by conflict-related violence and landmines were civilians. The report documents 1,982 massacres between 1980 and 2012. The Government also began a process of assistance, attention, and comprehensive reparation for victims of conflict.
Sources: en.wikipedia.org
==== Sri Lanka ==== In Sri Lanka, where poultry is the leading livestock industry and constitutes the only meat export industry, the majority of broiler chickens are mechanically processed in semi-automated plants. However, poultry is still slaughtered in traditional markets that generally cater to specific groups of customers and ethnic groups. A 2017 study of 102 semi-automated poultry processing plants and 25 poultry-slaughtering markets found that 27.4% of the broiler neck skin samples from the semi-automated processing facilities tested positive for Campylobacter contamination, while 48% of broiler neck skin samples from the market processing facilities tested positive for Campylobacter contamination.
== Ownership == In 2013, Bain Capital acquired an 80% controlling interest in BPL, previously wholly owned by the UK Government. Three years later, the shareholders decided to sell BPL Holdings to Creat, an investment company based in Beijing that owns part of a plasma fractionator in China. In 2022, Permira and Marcucci entered into an agreement to acquire and merge BPL and Kedrion operations into one venture. As a result, the new company would inherit the shareholders of the companies involved, requiring the support of its co-investors. In this case, FSI, CDP Equity and the other Kedrion shareholders had their shares transferred to the new company. In turn, to complete the agreement, the family group received the support of its co-investors, Ampersand Capital Partners and a wholly owned subsidiary of Abu Dhabi Investment Authority (ADIA). In 2023, the BPL site became known as Kedrion Elstree although its product portfolio continued to be marketed as 'BPL'.
Type 2 diabetes is due to insulin resistance. As the disease progresses, there is often an increase of insulin production by beta cells, leading to a higher level of insulin in the blood (hyperinsulinemia), but the increased level of insulin is eventually insufficient to control the glucose concentration. Insulin resistance refers to the inability of cells to respond adequately to normal levels of insulin, at the molecular level of pathological mechanism, this is typically due to impairment of the insulin signal transduction pathway—specifically, aberrant inhibition of one or more proximal components in the signaling cascade downstream of the insulin receptor, such as the insulin receptor itself, insulin receptor substrate (IRS) proteins, or AKT. Insulin resistance occurs within the muscles, liver, and fat tissue. In the liver, insulin normally suppresses glucose release. However, in the setting of insulin resistance, the liver inappropriately releases glucose into the blood. The proportion of insulin resistance versus beta cell dysfunction differs among individuals, with some having primarily insulin resistance and only a minor defect in insulin secretion and others with slight insulin resistance and primarily a lack of insulin secretion. Importantly, insulin resistance also occurs within pancreatic islet β-cells themselves. Because normal β-cell function depends on intact insulin signaling within the β-cell, disruption of this pathway can impair insulin production and secretion, contributing to β-cell dysfunction of type 2 diabetes.
The American tea culture is a part of the history of the United States, as tea has appealed to all classes and has adapted to the customs of the United States. The Native peoples of North America drank various herbal teas, the most common of which was Yaupon tea, known as the "Beloved drink", "Cassina", or "White drink". It was brewed from yaupon holly (Ilex vomitoria), which is native to the Atlantic and Gulf Coasts. Native American tribes like the Chickasaw, Cherokee, Choctaw, Muscogee, and Timucua used the tea as a daily drink, as a social drink used in meetings, and in various rituals, many of which were associated with purification. Yaupon tea was adopted by European colonists as early as the 17th century who gave it various names like "Black drink", "Carolina Tea", "South Seas Tea", or "Indian tea".
Clinton. In October 2002 at the International Symposium on Chromatography in London, Klaus Mosbach was presented the Martin Gold Medal, at the Royal Society, for the year 2000, by the Executive Committee of the Chromatographic Society. It was awarded him "in recognition of his major contributions to the field of separation science over many years". Previous recipients of this award are inter alia F. Regnier (1993), C. Horvath (1994) and W.H. Pirkle (1990). Mosbach published more than 537 peer reviewed scientific articles and reviews with an H-Index of 77. Mosbach wrote and edited four volumes of methods in enzymology series on Immobilized Enzymes, by Academic press (44,132,133,134). In addition he has received and applied for 84 patents.
Sources: en.wikipedia.org
Laminin G domain: all laminin alpha chains (LAMA1, LAMA2, LAMA3, LAMA4, LAMA5), cadherin EGF LAG seven-pass G-type receptors (CELSR1, CELSR2, CELSR3), contactin-associated proteins (CNTNAP1, CNTNAP2, CNTNAP3, CNTNAP3B, CNTNAP4, CNTNAP5), some collagens (COL5A1, COL5A3, COL9A1, COL11A1, COL11A2, COL12A1, COL14A1, COL15A1, COL16A1, COL18A1, COL19A1, COL20A1, COL21A1, COL22A1, COL24A1, COL27A1), crumbs homologs 1 and 2 (CRB1, CRB2), fat homologs (FAT1, FAT2, FAT3, FAT4), NEL-like proteins (NELL1, NELL2), neurexins (NRXN1, NRXN2, NRXN3), slit homologs (SLIT1, SLIT2, SLIT3), thrombospondins (THBS1, THBS2, THBS3, THBS4, TSPEAR), agrin (AGRIN), chondroitin sulfate proteoglycan 4 (CSPG4), eyes shut homolog (EYS), growth arrest-specific protein 6 (GAS6), perlecan (HSPG2), pikachurin (EGFLAM), protein S (PROS1), sex hormone-binding globulin (SHBG) and usherin (USH2A) Laminin N-terminal (domain VI): most laminin chains (LAMA1, LAMA2, LAMA3, LAMA5, LAMB1, LAMB2, LAMB3, LAMB4, LAMC1, LAMC3), most netrins (NTN1, NTN3, NTN4, NTNG1, NTNG2), and usherin (USH2A)
noble gas Also inert gas. Any of the six non-metallic elements of Group 18 of the periodic table: helium (He), neon (Ne), argon (Ar), krypton (Kr), xenon (Xe), and radon (Rn). All of the noble gases have outer electron shells that are completely filled with valence electrons in their naturally occurring states, giving them very low or negligible chemical reactivity.
=== Low-throughput === The mentioned drawbacks limit the reasonable use of automated in-gel digestion systems to the routine laboratory whereas the research laboratory with a demand to make a flexible use of the instruments of protein identification more often stays with the manual, low-throughput methods for in-gel digestion and MS analysis. This group of customers is targeted by the industry with several kit systems for in-gel digestion. Most of the kit systems are mere collections of the chemicals and enzymes needed for the in-gel digestion whereas the underlying protocol remains unchanged from the manual standard procedure described above. The advantage of these products for the inexperienced customer lies in the guaranteed functioning of the diverse solutions in combination with a ready-made protocol for the process. A few companies have tried to improve the handling process of in-gel digestion to allow even with manual sample preparation an easier and more standardised workflow. The Montage In-Gel Digest Kit from Millipore is based on the standard protocol, but enables processing of a large number of parallel samples by transferring the handling of the gel pieces to a modified 96 well microplate. The solutions for the diverse steps of in-gel digestion are pipetted into the wells of this plate whereas the removal of liquids is performed through the bottom of the wells by a vacuum pump. This system simplifies the handling of the multiple pipetting steps by the use of multichannel pipettes and even pipetting robots.
=== B.P.C. Payments to Nauruans === Under a policy established under the German administration, royalty payments were given to landowners. In 1921, the British Phosphate Commissioners (under pressure from the Nauruan people) increased royalty payments from one-half pence to one and one-half pence per ton of phosphate extracted. In 1927, a new agreement was reached, giving the Nauruans seven and one-half pence per ton. By 1939, Nauruans were receiving 9% of the phosphate revenues. This amount is still somewhat insignificant because at this time, Nauruan phosphate was selling far below world market prices.
Sources: en.wikipedia.org
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.
Single-receptor agents act predominantly at GLP-1R. Tirzepatide retains activity at GIPR, which is expressed in pancreatic islets, adipose tissue, and the central nervous system. The contribution of each receptor to the overall response is still an area of active study, and the relative weight of GIPR signaling in humans is not fully settled.
The fatty diacid moiety binds serum albumin, which reduces renal filtration of the active peptide. Additional resistance to enzymatic breakdown comes from non-natural residues in the backbone. Together these features produce an apparent half-life of about five days and permit weekly dosing intervals.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.